Evidence map›Paper›PMID 41625873›Full record

ArticleCureus2025

Olanzapine Overdose in an Adult Male Presenting With Altered Sensorium and Pinpoint Pupil: A Case Report.

Mohammad Abdurrahman Khan, Manisha Verma, Kahkashan Riaz

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohammad Abdurrahman KhanDepartment of Forensic Medicine and Toxicology, Hind Institute of Medical Sciences, Barabanki, Lucknow, IND.
Manisha VermaDepartment of Dentistry, Hind Institute of Medical Sciences, Barabanki, Lucknow, IND.
Kahkashan RiazDepartment of Pathology, Integral Institute of Medical Sciences and Research, Lucknow, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olanzapine is an atypical antipsychotic prescribed for various mental illnesses such as psychosis, schizophrenia, depression, and bipolar disorder. An overdose of olanzapine leads to many adverse effects, such as agitation, tachycardia, extrapyramidal dystonia, dysarthria, blurred vision, myosis, hypotension, respiratory depression, and deep coma. Yet, no antidote is available for olanzapine poisoning, and, hence, supportive care is a mainstay of management. A 51-year-old male presented to the emergency department in an unconscious state with an alleged history of drug overuse, with the ingestion of 10 tablets of olanzapine 10 mg. The patient was intubated. After intubation, Ryle's tube was inserted, and gastric lavage was performed using 300 mL of normal saline. The rest of the treatment was supportive. Prompt clinical evaluation, along with thorough history-taking from patients or family members, is a crucial step in patient management and thereby improving the outcome. Increasing awareness among healthcare providers about toxicity due to olanzapine overdose is an important step for assuring early intervention and improving patient care.

Indexed as

antipsychoticolanzapineoverdosepoisoningtoxicity

Identifiers

PMID41625873
PMCPMC12859379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.